BVXP On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt

bioventix plc (BVXP) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOVENTIX PLC (BVXP)
\

Related News

No related news articles were found.

bioventix plc (BVXP) Related Businessweek News

No Related Businessweek News Found

bioventix plc (BVXP) Details

Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. The company was founded in 2003 and is based in London, the United Kingdom.

12 Employees
Last Reported Date: 11/9/18
Founded in 2003

bioventix plc (BVXP) Top Compensated Officers

CEO & Director
Total Annual Compensation: 321.4K GBP
Compensation as of Fiscal Year 2018.
bioventix plc
Bioventix plc Announces First Interim Dividend, Payable on April 26, 2019

The Board of directors of Bioventix plc announced a first interim dividend of 30 pence per share which represents a 20% increase on first half of 2018. The shares will be marked ex-dividend on 11 April 2019 and the dividend will be paid on 26 April 2019 to shareholders on the register at close of business on 12 April 2019.

Bioventix PLC Reports Unaudited Earnings Results for the Half-Year Ended December 31, 2018

Bioventix PLC reported unaudited earnings results for the half-year ended December 31, 2018. For the half year, turnover was GBP 4,364,665 against GBP 3,522,636 a year ago. Operating profit was GBP 3,236,337 against GBP 3,390,409 a year ago. Profit for the period was GBP 2,746,816 against GBP 2,822,498 a year ago. Earnings per basic share were 53.44 pence against 55.03 pence a year ago. Earnings per diluted share were 52.54 pence against 54.08 pence a year ago.

Bioventix PLC Presents at Mello London Investor Conference, Nov-26-2018 through Nov-27-2018

Bioventix PLC Presents at Mello London Investor Conference, Nov-26-2018 through Nov-27-2018. Venue: Clayton Hotel Chiswick, 626 Chiswick High Road, London, United Kingdom. Presentation Date & Speakers: Nov-26-2018, Peter J. Harrison, CEO & Director.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

BVXP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BVXP.
View Industry Companies
 

Industry Analysis

BVXP

Industry Average

Valuation BVXP Industry Range
Price/Earnings 34.6x
Price/Sales 21.5x
Price/Book 20.7x
Price/Cash Flow 34.0x
TEV/Sales 21.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BIOVENTIX PLC, please visit www.bioventix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.